Newbridge Securities acted as sole book running manager for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GANX:
- Gain Therapeutics announces common stock, warrants offering
- Buy Rating for Gain Therapeutics Driven by Accelerated Clinical Progress and Valuation Model
- Promising Developments and Strategic Advancements Propel Gain Therapeutics to ‘Buy’ Rating
- Positive Outlook for Gain Therapeutics Amid Promising Biomarker Developments and Clinical Trial Progress
- Gain Therapeutics Advances Phase 1b Parkinson’s Study